[Slowly progressive IDDM (SPIDDM)].
Kobayashi
T
T
Department of Endocrinology and Metabolism, Toranomon Hospital.
D001323:Autoantibodies / Q000032:analysis; D015415:Biomarkers / Q000032:analysis; D003922:Diabetes Mellitus, Type 1 / Q000503:physiopathology* / Q000517:prevention & control; D018450:Disease Progression; D005968:Glutamate Decarboxylase / Q000276:immunology; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D007330:Insulin Antibodies / Q000276:immunology; D007515:Islets of Langerhans / Q000473:pathology; D013997:Time Factors
D001323:Autoantibodies; D015415:Biomarkers; D007004:Hypoglycemic Agents; D007328:Insulin; D007330:Insulin Antibodies; D005968:Glutamate Decarboxylase